FREE Case Review (866) 588-0600

Court Establishes Benefit and Expense Funds for Invokana MDL

A Common Benefit Fee and Expense Fund has been established in the Invokana multidistrict litigation for expenses incurred during the litigation process.

A Common Benefit Fee and Expense Fund has been established in the Invokana multidistrict litigation (MDL No. 2750) “to provide for the fair and equitable sharing among plaintiffs and their counsel” for expenses incurred during the litigation process.

Free Confidential Lawsuit Evaluation: If you or a loved one got diabetic ketoacidosis or kidney disease from Invokana, you should contact our law firm immediately. You may be entitled to compensation by filing a suit and our lawyers can help.

What’s the Problem?

According to a Pretrial Order (PDF) issued March 21, 2017, the funds apply to all Invokana and Invokamet lawsuits pending in MDL No. 2750.

“Common benefit work product includes all work performed for the benefit of all plaintiffs, including pre-trial matters, discovery, trial preparation, a potential settlement process, and all other work that advances this litigation to conclusion,” the Order states.

Last December, a panel of judges ordered that all Invokana and Invokamet lawsuits filed on the federal level would be transferred to the District of New Jersey as part of an MDL to be overseen by Judge Brian R. Martinotti. At the time of the filing, the litigation included about 55 lawsuits alleging that the medications may cause a number of serious injuries, and that Janssen failed to adequately warn about these risks. The cases have enough similarity to consolidate for the sake of simplifying and expediting the litigation, according to the JPML.

“The actions share factual questions arising from allegations that taking Invokana or Invokamet may result in patients suffering various injuries, including diabetic ketoacidosis and kidney damage,” the panel stated in its Transfer Order. “The actions thus implicate numerous common issues concerning the development, manufacture, testing, regulatory history, promotion, and labeling of the drugs.”

In May 2015, the FDA issued a Drug Safety Communication stating that Invokana, Invokamet and other type 2 diabetes medications from the SGLT2 inhibitor class had been linked to kidney failure and diabetic ketoacidosis (also known as DKA, diabetic acidosis, metabolic ketoacidosis or ketoacidosis). This condition occurs when cells in the body are unable to get the glucose they need for energy, causing symptoms such as fatigue, confusion, difficulty breathing and frequent urination.

Do I Have an Invokana Lawsuit?

The Pharmaceutical Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Invokana lawsuits. We are handling individual litigation nationwide and currently accepting new DKA and kidney failure cases in all 50 states.

Free Case Evaluation: Again, if you were injured by Invokana side effects, you should contact our law firm immediately. You may be entitled to a settlement by filing a suit and we can help.

Free Confidential Case Evaluation

Verified 100% Secure SiteTo contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing: (866) 588-0600.
*
*
*

Awards & recognition